Lobbying Income
$4.9M
Filings
268
Unique Clients
10
Active Period
2005–2016
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Cancer Care Payment Reform Act of 2015
2016 · fourth_quarter · Client: FARRAGUT PARTNERS ON BEHALF OF COMMUNITY ONCOLOGY ALLIANCE
H.R. 1934- Cancer Care Payment Reform Act of 2015 Medicare Part B reimbursement Part B drug payment model S.3211- Cancer Care Payment Reform Act of 2016
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1934
Cancer Care Payment Reform Act of 2016
2016 · fourth_quarter · Client: FARRAGUT PARTNERS ON BEHALF OF COMMUNITY ONCOLOGY ALLIANCE
H.R. 1934- Cancer Care Payment Reform Act of 2015 Medicare Part B reimbursement Part B drug payment model S.3211- Cancer Care Payment Reform Act of 2016
Client expense: — · Firm income: $20,000
Matched citations: S.3211
Medicare Choices Empowerment and Protection Act
2016 · fourth_quarter · Client: ADVAULT, INC.
Encouraging the adoption of digital advance care plans S.2297; HR.4059-- Medicare Choices Empowerment and Protection Act
Client expense: — · Firm income: $15,000
Matched citations: HR.4059
Medicare Choices Empowerment and Protection Act
2016 · fourth_quarter · Client: ADVAULT, INC.
Encouraging the adoption of digital advance care plans S.2297; HR.4059-- Medicare Choices Empowerment and Protection Act
Client expense: — · Firm income: $15,000
Matched citations: S.2297
Ambulatory Surgical Center Quality and Access Act of 2015
2016 · fourth_quarter · Client: THE ASC ASSOCIATION
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use S.1347- The Electronic Health Fairness Act of 2015
Client expense: — · Firm income: $20,000
Matched citations: HR 1453
Electronic Health Fairness Act of 2015
2016 · fourth_quarter · Client: THE ASC ASSOCIATION
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use S.1347- The Electronic Health Fairness Act of 2015
Client expense: — · Firm income: $20,000
Matched citations: S.1347
Ambulatory Surgical Center Quality and Access Act of 2015
2016 · fourth_quarter · Client: THE ASC ASSOCIATION
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use S.1347- The Electronic Health Fairness Act of 2015
Client expense: — · Firm income: $20,000
Matched citations: S.2071
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
2016 · fourth_quarter · Client: AMERISOURCEBERGEN CORPORATION
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act
Client expense: — · Firm income: $20,000
Matched citations: H.R. 471
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2016 · fourth_quarter · Client: AMERISOURCEBERGEN CORPORATION
Pharmaceutical distribution management ASP reimbursement policy under Medicare Part B S.506/H.R.696- A bill to exclude prompt pay discount from calculation of ASP Part B drug payment demonstration
Client expense: — · Firm income: $20,000
Matched citations: H.R.696
Ensuring Patient Access and Effective Drug Enforcement Act of 2016
2016 · fourth_quarter · Client: AMERISOURCEBERGEN CORPORATION
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act
Client expense: — · Firm income: $20,000
Matched citations: S.483
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2016 · fourth_quarter · Client: AMERISOURCEBERGEN CORPORATION
Pharmaceutical distribution management ASP reimbursement policy under Medicare Part B S.506/H.R.696- A bill to exclude prompt pay discount from calculation of ASP Part B drug payment demonstration
Client expense: — · Firm income: $20,000
Matched citations: S.506
Cancer Care Payment Reform Act of 2015
2016 · third_quarter · Client: FARRAGUT PARTNERS ON BEHALF OF COMMUNITY ONCOLOGY ALLIANCE
H.R. 1934- Cancer Care Payment Reform Act of 2015 Medicare Part B reimbursement Part B drug payment model S.3211- Cancer Care Payment Reform Act of 2016
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1934
Cancer Care Payment Reform Act of 2016
2016 · third_quarter · Client: FARRAGUT PARTNERS ON BEHALF OF COMMUNITY ONCOLOGY ALLIANCE
H.R. 1934- Cancer Care Payment Reform Act of 2015 Medicare Part B reimbursement Part B drug payment model S.3211- Cancer Care Payment Reform Act of 2016
Client expense: — · Firm income: $20,000
Matched citations: S.3211
Medicare Choices Empowerment and Protection Act
2016 · third_quarter · Client: ADVAULT, INC.
Encouraging the adoption of digital advance care plans S.2297; HR.4059-- Medicare Choices Empowerment and Protection Act
Client expense: — · Firm income: $15,000
Matched citations: HR.4059
Medicare Choices Empowerment and Protection Act
2016 · third_quarter · Client: ADVAULT, INC.
Encouraging the adoption of digital advance care plans S.2297; HR.4059-- Medicare Choices Empowerment and Protection Act
Client expense: — · Firm income: $15,000
Matched citations: S.2297
Ambulatory Surgical Center Quality and Access Act of 2015
2016 · third_quarter · Client: THE ASC ASSOCIATION
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use S.1347- The Electronic Health Fairness Act of 2015
Client expense: — · Firm income: $20,000
Matched citations: HR 1453
Electronic Health Fairness Act of 2015
2016 · third_quarter · Client: THE ASC ASSOCIATION
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use S.1347- The Electronic Health Fairness Act of 2015
Client expense: — · Firm income: $20,000
Matched citations: S.1347
Ambulatory Surgical Center Quality and Access Act of 2015
2016 · third_quarter · Client: THE ASC ASSOCIATION
HR 1453- The ASC Quality and Access Act S.2071 The ASC Quality and Access Act Electronic Medical records/Meaningful use S.1347- The Electronic Health Fairness Act of 2015
Client expense: — · Firm income: $20,000
Matched citations: S.2071
Ensuring Patient Access and Effective Drug Enforcement Act of 2015
2016 · third_quarter · Client: AMERISOURCEBERGEN CORPORATION
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act
Client expense: — · Firm income: $20,000
Matched citations: H.R. 471
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2016 · third_quarter · Client: AMERISOURCEBERGEN CORPORATION
Pharmaceutical distribution management ASP reimbursement policy under Medicare Part B S.506/H.R.696- A bill to exclude prompt pay discount from calculation of ASP Part B drug payment demonstration
Client expense: — · Firm income: $20,000
Matched citations: H.R.696
Ensuring Patient Access and Effective Drug Enforcement Act of 2016
2016 · third_quarter · Client: AMERISOURCEBERGEN CORPORATION
H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act
Client expense: — · Firm income: $20,000
Matched citations: S.483
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
2016 · third_quarter · Client: AMERISOURCEBERGEN CORPORATION
Pharmaceutical distribution management ASP reimbursement policy under Medicare Part B S.506/H.R.696- A bill to exclude prompt pay discount from calculation of ASP Part B drug payment demonstration
Client expense: — · Firm income: $20,000
Matched citations: S.506
Cancer Care Payment Reform Act of 2015
2016 · second_quarter · Client: FARRAGUT PARTNERS ON BEHALF OF COMMUNITY ONCOLOGY ALLIANCE
H.R. 1934- Cancer Care Payment Reform Act of 2015 Medicare Part B reimbursement Part B drug payment model S.3211- Cancer Care Payment Reform Act of 2016
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1934
Cancer Care Payment Reform Act of 2016
2016 · second_quarter · Client: FARRAGUT PARTNERS ON BEHALF OF COMMUNITY ONCOLOGY ALLIANCE
H.R. 1934- Cancer Care Payment Reform Act of 2015 Medicare Part B reimbursement Part B drug payment model S.3211- Cancer Care Payment Reform Act of 2016
Client expense: — · Firm income: $20,000
Matched citations: S.3211
Comprehensive Addiction and Recovery Act of 2015
2016 · second_quarter · Client: GILEAD SCIENCES, INC.
Coverage and reimbursement policy for HCV and HIV portfolio S.524/H.R.953-The Comprehensive Addiction and Recovery Act (CARA)
Client expense: — · Firm income: $20,000
Matched citations: H.R.953
Source: Senate LDA